Generic Name
Glyceryl trinitrate
Also Known As
Nitroglycerin
Trinitrin
1,2,3-Trinitroxypropane
Brand Names
Nitrolingual
Nitrostat
Nitromint
Nitro-Bid
Rectogesic
Transiderm-Nitro
Nitro-Dur
Minitran
Available in multiple formulations: sublingual tablets, buccal sprays, ointments, transdermal patches, intravenous solution, rectal ointment
Drug Class
Organic nitrate
Vasodilator
Anti-anginal agent
Mechanism of Action
GTN is converted enzymatically into nitric oxide (NO), a potent endogenous vasodilator
NO activates guanylate cyclase in vascular smooth muscle leading to increased levels of cyclic GMP
Elevated cGMP causes dephosphorylation of myosin light chains resulting in smooth muscle relaxation
Predominantly causes venodilation, reducing preload and myocardial oxygen demand
At higher doses, GTN also dilates arterial vessels, decreasing afterload
Relieves coronary vasospasm and improves subendocardial perfusion
Also reduces esophageal tone in rectal or esophageal use
Indications
Relief and prevention of angina pectoris (chronic stable, variant, and unstable angina)
Acute coronary syndrome (ACS)
Hypertensive emergencies (IV GTN)
Acute decompensated heart failure
Perioperative blood pressure control
Anal fissures (topical rectal ointment)
Off-label: esophageal spasm, pulmonary hypertension (limited), Raynaud’s phenomenon (topical)
Dosage and Administration
Sublingual Tablets
0.3 mg, 0.5 mg, or 0.6 mg placed under tongue during angina attack
May repeat every 5 minutes up to 3 doses within 15 minutes
If no relief after first dose, seek emergency care
Sublingual Spray
400 micrograms/spray
1–2 sprays under the tongue at angina onset
May repeat at 5-minute intervals (max 3 sprays in 15 minutes)
Transdermal Patches
5 mg to 15 mg released over 24 hours
Apply to hairless area of chest or upper arm
Used for angina prophylaxis
Apply patch daily and remove after 12–14 hours to prevent tolerance
Topical Ointment (e.g. Nitro-Bid 2%)
Measured in inches (e.g. 1–2 inches) on dosing paper
Applied to chest or upper arm every 6–8 hours
Used in angina prevention and heart failure
Rectal Ointment (e.g. Rectogesic 0.2%)
Apply ~1.5 cm to anal canal every 12 hours
Indicated for chronic anal fissures
Intravenous Infusion
Used in acute heart failure, hypertensive crisis, or unstable angina
Initial rate: 5 mcg/min, titrate by 5 mcg/min every 3–5 min
Max rate often ~200 mcg/min
Administer via infusion pump with glass container (polyvinyl chloride absorbs GTN)
Pediatric Use
Not routinely used in children except under specialist care
Geriatric Use
Initiate at lower doses due to increased sensitivity to hypotensive effects
Pharmacokinetics
Bioavailability low due to first-pass metabolism (oral forms rarely used)
Onset:
– Sublingual tablets/spray: 1–3 min
– Ointment: 15–60 min
– Patch: 30–60 min
– IV: immediate
Duration:
– Sublingual: 30–60 min
– Patch: up to 24 hours
Metabolized by liver and vascular tissue
Half-life: 1–4 minutes
Excreted via urine
Contraindications
Hypersensitivity to nitrates
Concurrent use of phosphodiesterase type 5 (PDE5) inhibitors (e.g. sildenafil, tadalafil, vardenafil)
Severe hypotension (SBP <90 mmHg)
Marked anemia
Increased intracranial pressure
Pericardial tamponade or restrictive cardiomyopathy
Constrictive pericarditis
Closed-angle glaucoma (topical formulations)
Shock or uncorrected hypovolemia
Warnings and Precautions
May cause significant hypotension, syncope, or reflex tachycardia
Develops tolerance with continuous exposure — nitrate-free interval required (typically 10–14 hours/day)
Abrupt withdrawal after prolonged use may worsen angina
May cause rebound hypertension (IV withdrawal)
Increased intracranial pressure with cerebral trauma
May worsen hypoxemia in patients with lung disease (impaired V/Q matching)
Headache is dose-dependent and may limit adherence
Use with caution in aortic/mitral stenosis due to risk of hypotension
Adverse Effects
Very Common
Headache (can be severe and persistent)
Flushing
Postural hypotension
Common
Dizziness
Reflex tachycardia
Palpitations
Nausea
Vomiting
Dermatitis (topical use)
Uncommon to Rare
Severe hypotension
Syncope
Paradoxical bradycardia
Methemoglobinemia (at very high doses)
Allergic skin reactions
Contact dermatitis with patches or ointment
Blurred vision (rare)
Pregnancy and Lactation
Pregnancy Category
Not officially classified in many regions
Limited data but not associated with major fetal risk
May be used if clinically necessary (e.g. heart failure, angina) under close monitoring
Lactation
Excreted in breast milk in low amounts
Use cautiously during breastfeeding
Drug Interactions
Phosphodiesterase Inhibitors (PDE5)
Sildenafil, tadalafil, vardenafil
Contraindicated — risk of profound hypotension, syncope, or MI
Other Antihypertensives
Beta-blockers, calcium channel blockers, ACE inhibitors
Additive hypotensive effect
Monitor blood pressure closely
Alcohol
May intensify vasodilation and hypotension
Avoid alcohol consumption
Ergot Alkaloids
May antagonize vasodilatory effects
Avoid concurrent use
Heparin
IV GTN may reduce heparin efficacy
Monitor aPTT and adjust heparin dose
Tricyclic Antidepressants/Antipsychotics
May increase postural hypotension
Monitoring Parameters
Relief of angina symptoms
Blood pressure and heart rate
Tolerance development — consider drug-free intervals
Headache severity (may require analgesia or dose adjustment)
Skin site irritation with patches
Signs of hypotension or syncope
ECG monitoring for IV use
Tolerance and adherence in chronic use
Counseling Points
Sit or lie down when taking sublingual GTN to avoid fainting
Place sublingual tablet under tongue; do not swallow or chew
If angina not relieved after 1 dose, seek emergency help after 5 minutes
Store sublingual tablets in original container; replace every 6 months
Avoid alcohol during therapy
Do not use erectile dysfunction drugs while on GTN
Rotate patch sites to avoid skin irritation
Remove patch at night to prevent tolerance
May cause headache; usually improves with continued use
Comparative Notes
GTN vs Isosorbide Mononitrate/Dinitrate
GTN is shorter-acting and used for acute angina
Isosorbide compounds are longer-acting and used for angina prophylaxis
GTN vs Beta-Blockers
GTN provides acute relief
Beta-blockers reduce heart rate and are more suitable for long-term angina control
GTN vs CCBs (e.g., amlodipine)
GTN works quickly but transiently
CCBs provide sustained anti-anginal effect and are used in vasospastic angina
Legal and Regulatory Status
Prescription-only for all injectable and patch forms
Sublingual forms often available OTC in emergency kits
Included in WHO Essential Medicines List
No comments:
Post a Comment